WASHINGTON, DC—Investors are confused – and may even be misled – by disclosures proposed by the Securities and Exchange Commission (SEC) to help investors choose an investment professional, according to independent testing conducted by Kleimann Communications Group on behalf of AARP, Consumer Federation of America (CFA), and the Financial Planning Coalition.

WASHINGTON, DC—Information stolen in computer breaches of well-known companies is flooding into an underground digital market called the Dark Web, where criminals buy and sell Social Security numbers, credit card information and computer passwords to be used for fraud, an investigation in the September issue of AARP Bulletin reveals. Using software originally developed by the U.S. Navy and available for free to anyone who wishes to download it, criminals buy and sell private data with complete anonymity, then use it to commit identity fraud. Approximately 6.6 percent of U.S. adults were victimized last year, the report shows, and allegedly, more than half of Americans’ Social Security numbers are for sale for as low as a few dollars each. The article also details how identity fraud typically occurs, and the many proven, powerful ways consumers can protect themselves.

WASHINGTON, D.C.—The Securities and Exchange Commission’s proposed “best interest” advice rule fails consumers with an ill-defined standard and confusing disclosure forms, according to an assessment by AARP.

WASHINGTON, DC—According to a new AARP survey of experienced workers, nearly 9 in 10 work for financial reasons, but approximately 8 in 10 either enjoy or feel useful doing their work. And among those who plan to retire, over 1 in 4 plans to start a business or earn money in some independent way, such as a gig economy job. Given employers’ need for talent, it makes great business sense to hire experienced workers, as demonstrated by additional AARP research.

WASHINGTON, DC—On June 25, AARP announced an unprecedented investment of $60 million in the Dementia Discovery Fund (DDF) the first and largest venture fund focused on discovering and developing effective new drugs for treating dementia and ultimately a cure. Now, a special report in the July/August issue of AARP Bulletin details the scope of this healthcare issue, provides a profile of DDF, and explains why research to date has yielded so few solutions, despite tens of billions of dollars being spent.